A German Federal Court decision has given patent applicants in the life sciences field plenty to think about, as Wolfgang Bublak and Axel Berger explain.

Life Sciences Intellectual Property Review Volume 1, Issue 1

Pubblicato il
November 2013
Axel B. Berger
German and European Patent Attorney, Partner*
Wolfgang Bublak